Cerity Partners LLC boosted its position in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 67.0% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 19,372 shares of the company's stock after purchasing an additional 7,774 shares during the quarter. Cerity Partners LLC's holdings in Molina Healthcare were worth $6,381,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the company. Wellington Management Group LLP grew its position in Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after purchasing an additional 181,073 shares during the last quarter. FMR LLC grew its position in Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after purchasing an additional 427,276 shares during the last quarter. Geode Capital Management LLC grew its position in Molina Healthcare by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after purchasing an additional 34,992 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after acquiring an additional 294,180 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Molina Healthcare by 15.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock valued at $200,307,000 after acquiring an additional 91,229 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on MOH. Robert W. Baird reaffirmed a "neutral" rating and set a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Guggenheim began coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Baird R W downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Morgan Stanley downgraded Molina Healthcare from an "overweight" rating to an "equal weight" rating and cut their price target for the company from $364.00 to $266.00 in a research note on Thursday, July 10th. Finally, Wall Street Zen downgraded shares of Molina Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Eleven investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Molina Healthcare has a consensus rating of "Hold" and an average price target of $347.57.
Get Our Latest Research Report on Molina Healthcare
Insider Buying and Selling at Molina Healthcare
In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the transaction, the director owned 11,244 shares of the company's stock, valued at $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer directly owned 257,715 shares in the company, valued at $82,484,262.90. This represents a 25.35% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.
Molina Healthcare Stock Down 4.2%
Molina Healthcare stock traded down $8.54 during midday trading on Friday, hitting $195.71. 593,087 shares of the company's stock were exchanged, compared to its average volume of 725,433. The company has a market cap of $10.61 billion, a PE ratio of 9.45, a P/E/G ratio of 0.90 and a beta of 0.55. The firm has a 50-day moving average of $284.56 and a two-hundred day moving average of $301.05. Molina Healthcare, Inc has a 12 month low of $193.51 and a 12 month high of $365.23. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.63 and a current ratio of 1.63.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The business's quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the previous year, the business posted $5.73 EPS. As a group, analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.